Fibricor Injection

Administered intravenously under strict medical supervision, Fibricor Injection is typically reserved for patients who require immediate restoration of normal heart rhythm due to symptomatic arrhythmias. The onset of action is rapid, making it an effective choice in acute settings. However, its use necessitates continuous cardiac monitoring due to the risk of proarrhythmia, including torsades de pointes, a potentially life-threatening ventricular tachyarrhythmia.

Dosage and administration must be carefully tailored based on patient response and clinical condition, with attention to electrolyte imbalances and other contraindications. Fibricor Injection should be used cautiously in patients with structural heart disease, electrolyte disturbances, or prolonged QT interval. Overall, Fibricor Injection is a valuable therapeutic option for managing atrial arrhythmias when rapid cardioversion is clinically indicated, contributing to improved cardiac function and symptom relief.